Lisa Dilworth | Vice President Rare And Orphan Diseases
Synteract

Lisa Dilworth, Vice President Rare And Orphan Diseases, Synteract

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 14:30

ROUNDTABLE 7: Meaningful endpoints – navigating the differences in what it means to patients, caregivers, physicians and regulators during advanced therapies clinical development

last published: 14/Mar/19 17:55 GMT

back to speakers